Skip to main content
Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis.
Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator.
Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research.
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease.
Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia.
Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease.
Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.
Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic function.
Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome.
Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.